Literature DB >> 11313013

Dissecting the host response to a gamma-herpesvirus.

P C Doherty1, J P Christensen, G T Belz, P G Stevenson, M Y Sangster.   

Abstract

The murine gamma-herpesvirus 68 (MHV-68) provides a unique experimental model for dissecting immunity to large DNA viruses that persist in B lymphocytes. The analysis is greatly facilitated by the availability of genetically disrupted (-/-) mice that lack key host-response elements, and by the fact that MHV-68 is a lytic virus that can readily be manipulated for mutational analysis. The mutant virus strategy is being used, for example, to characterize the part played in vivo by an MHV-68-encoded chemokine-binding protein that may ultimately find an application in human therapeutics. Experiments with various -/- mice and monoclonal antibody depletion protocols have shown very clearly that type I interferons (IFNs) are essential for the early control of MHV-68 replication, while CD4+ T cells producing IFN-gamma function to limit the consequences of viral persistence. Virus-specific CD8+ effectors acting in the absence of the CD4+ subset seem initially to control the lytic phase in the lung following respiratory challenge, but are then unable to prevent the reactivation of replicative infection in epithelia and the eventual death of CD4+ T-cell-deficient mice. This could reflect the fact that the interaction between the CD8+ T cells and the virus-infected targets is partially compromised by the MHV-68 K3 protein, which inhibits antigen presentation by MHC class I glycoproteins. Immunization strategies focusing on the CD8+ T-cell response to epitopes expressed during the lytic phase of MHV-68 infection can limit virus replication, but are unable to prevent the establishment of latency. Other experiments with mutant viruses also suggest that there is a disconnection between lytic MHV-68 infection and latency. The massive nonspecific immunoglobulin response and the dramatic expansion of Vbeta4+ CD8+ T cells, which is apparently MHC independent, could represent some sort of 'smoke screen' used by MHV-68 to subvert immunity. Although MHV-68 is neither Epstein-Barr virus nor human herpesvirus-8, the results generated from this system suggest possibilities that may usefully be addressed with these human pathogens. Perhaps the main lesson learned to date is that all the components of immunity are likely to be important for the control of these complex viruses.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11313013      PMCID: PMC1088446          DOI: 10.1098/rstb.2000.0786

Source DB:  PubMed          Journal:  Philos Trans R Soc Lond B Biol Sci        ISSN: 0962-8436            Impact factor:   6.237


  111 in total

1.  The murine gammaherpesvirus-68 M11 protein inhibits Fas- and TNF-induced apoptosis.

Authors:  Guang-Hua Wang; Tara L Garvey; Jeffrey I Cohen
Journal:  J Gen Virol       Date:  1999-10       Impact factor: 3.891

Review 2.  Murine gammaherpesvirus 68: a model for the study of gammaherpesvirus pathogenesis.

Authors:  J P Simas; S Efstathiou
Journal:  Trends Microbiol       Date:  1998-07       Impact factor: 17.079

3.  The numbers game for virus-specific CD8+ T cells.

Authors:  P C Doherty
Journal:  Science       Date:  1998-04-10       Impact factor: 47.728

4.  Inflammatory cytokines and the reactivation of Kaposi's sarcoma-associated herpesvirus lytic replication.

Authors:  J Chang; R Renne; D Dittmer; D Ganem
Journal:  Virology       Date:  2000-01-05       Impact factor: 3.616

5.  Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection.

Authors:  K Murali-Krishna; J D Altman; M Suresh; D J Sourdive; A J Zajac; J D Miller; J Slansky; R Ahmed
Journal:  Immunity       Date:  1998-02       Impact factor: 31.745

6.  Hierarchical and redundant lymphocyte subset control precludes cytomegalovirus replication during latent infection.

Authors:  B Polić; H Hengel; A Krmpotić; J Trgovcich; I Pavić; P Luccaronin; S Jonjić; U H Koszinowski
Journal:  J Exp Med       Date:  1998-09-21       Impact factor: 14.307

7.  Direct visualization of antigen-specific CD8+ T cells during the primary immune response to Epstein-Barr virus In vivo.

Authors:  M F Callan; L Tan; N Annels; G S Ogg; J D Wilson; C A O'Callaghan; N Steven; A J McMichael; A B Rickinson
Journal:  J Exp Med       Date:  1998-05-04       Impact factor: 14.307

8.  A new look at T cells.

Authors:  A J McMichael; C A O'Callaghan
Journal:  J Exp Med       Date:  1998-05-04       Impact factor: 14.307

9.  Lung epithelial cells are a major site of murine gammaherpesvirus persistence.

Authors:  J P Stewart; E J Usherwood; A Ross; H Dyson; T Nash
Journal:  J Exp Med       Date:  1998-06-15       Impact factor: 14.307

10.  Interferon gamma regulates acute and latent murine cytomegalovirus infection and chronic disease of the great vessels.

Authors:  R M Presti; J L Pollock; A J Dal Canto; A K O'Guin; H W Virgin
Journal:  J Exp Med       Date:  1998-08-03       Impact factor: 14.307

View more
  72 in total

1.  Gammaherpesvirus lytic gene expression as characterized by DNA array.

Authors:  Joo Wook Ahn; Kenneth L Powell; Paul Kellam; Dagmar G Alber
Journal:  J Virol       Date:  2002-06       Impact factor: 5.103

2.  Sleep and fatigue in mice infected with murine gammaherpesvirus 68.

Authors:  Melissa D Olivadoti; Jason B Weinberg; Linda A Toth; Mark R Opp
Journal:  Brain Behav Immun       Date:  2011-01-24       Impact factor: 7.217

3.  Effective vaccination against long-term gammaherpesvirus latency.

Authors:  Scott A Tibbetts; J Scott McClellan; Shivaprakash Gangappa; Samuel H Speck; Herbert W Virgin
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

4.  Maintenance of gammaherpesvirus latency requires viral cyclin in the absence of B lymphocytes.

Authors:  Linda F van Dyk; Herbert W Virgin; Samuel H Speck
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

5.  Critical role of CD4 T cells in an antibody-independent mechanism of vaccination against gammaherpesvirus latency.

Authors:  James Scott McClellan; Scott A Tibbetts; Shivaprakash Gangappa; Kelly A Brett; Herbert W Virgin
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

6.  Expression in a recombinant murid herpesvirus 4 reveals the in vivo transforming potential of the K1 open reading frame of Kaposi's sarcoma-associated herpesvirus.

Authors:  Jill Douglas; Bernadette Dutia; Susan Rhind; James P Stewart; Simon J Talbot
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

7.  Dendritic cells loaded with tumor B cells elicit broad immunity against murine gammaherpesvirus 68 but fail to prevent long-term latency.

Authors:  Janet Weslow-Schmidt; Fang Ye; Stephanie S Cush; Kathleen A Stuller; Marcia A Blackman; Emilio Flaño
Journal:  J Virol       Date:  2010-06-30       Impact factor: 5.103

8.  Impaired pulmonary immunity post-bone marrow transplant.

Authors:  Stephanie M Coomes; Leah L N Hubbard; Bethany B Moore
Journal:  Immunol Res       Date:  2011-05       Impact factor: 2.829

Review 9.  Living in a house of cards: re-evaluating CD8+ T-cell immune correlates against HIV.

Authors:  George Makedonas; Michael R Betts
Journal:  Immunol Rev       Date:  2011-01       Impact factor: 12.988

10.  Infection of dendritic cells by a gamma2-herpesvirus induces functional modulation.

Authors:  Emilio Flaño; Basak Kayhan; David L Woodland; Marcia A Blackman
Journal:  J Immunol       Date:  2005-09-01       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.